Multiple Sclerosis

<ol> <li>Clinical manifestations of multiple sclerosis: An overview</li> <li>Novel Therapies for Multiple Sclerosis: A Mechanistic View</li> <li>Role of B cells in the pathogenesis of MS: Mechanisms of action</li> <li>Role of CD4+ T cells in the pathophysiology of MS</li> <li>GM-CSF in Central Nervous System Autoimmunity</li> <li>Role of cytokine-mediated crosstalk between T cells and non-immune cells in the pathophysiology of multiple sclerosis</li> <li>Vitamin D: role in pathogenesis of Multiple Sclerosis</li> <li>Role of genetic factors in pathogenesis of MS</li> <li>Neuropathology of multiple sclerosis</li> <li>Pathophysiology of acute disseminated encephalomyelitis</li> <li>Pathophysiology of experimental autoimmune encephalomyelitis</li> <li>Pathophysiology of optic neuritis</li> <li>Neurodegeneration and Remyelination in Multiple Sclerosis</li> <li>Mechanisms of action of Glatiramer Acetate in the treatment of multiple sclerosis</li> <li>Mechanism of Action of Interferon Beta in Treatment of Multiple Sclerosis</li> <li>Mechanisms of blood brain barrier disintegration in the pathophysiology of MS</li> <li>Mechanisms and potentials of Stem Cells in the treatment of Multiple Sclerosis: The unpaved path</li> <li>Role of neuroimaging in MS</li> <li>Pathophysiology of Lymphatic Drainage of the Central Nervous System. Implications for the Pathophysiology of Multiple Sclerosis<br></li></ol>